Stoke Therapeutics, Inc.
STOK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$38 | -$23 | $113 | -$10 |
| Dep. & Amort. | $1 | $0 | $0 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $8 | $7 | $7 |
| Change in WC | -$1 | -$11 | $12 | -$20 |
| Other Non-Cash | $8 | $1 | $0 | -$0 |
| Operating Cash Flow | -$30 | -$25 | $132 | -$23 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$24 | -$182 | -$19 | -$29 |
| Inv. Sales/Matur. | $33 | $33 | $33 | $30 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $9 | -$148 | $14 | $1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3 | $1 | $1 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1 |
| Financing Cash Flow | $3 | $1 | $1 | $1 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$18 | -$173 | $147 | -$22 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $102 | $276 | $129 | $151 |
| End Cash | $83 | $102 | $276 | $129 |
| Free Cash Flow | -$30 | -$26 | $132 | -$23 |